NCT07549048

Brief Summary

Individuals aged 18-80 years who have been clinically diagnosed with multiple sclerosis and their caregivers will be included in the study. Demographic data of the patients, including age, height, weight, and comorbidities, will be recorded. Disease-specific characteristics such as disease duration, presence of incontinence, ambulation status, and presence and severity of pain will be assessed. Functional status of the patients will be evaluated using the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Impact Scale (MSIS). Symptoms related to depression and anxiety in patients will be assessed using the Hospital Anxiety and Depression Scale (HADS). Subsequently, caregivers of the patients will be evaluated. The severity of insomnia will be assessed using the Insomnia Severity Index (ISI). Symptoms related to anxiety and depression will be evaluated using the Hospital Anxiety and Depression Scale (HADS). Caregiver burden will be assessed using the Zarit Caregiver Burden Scale.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
0mo left

Started Apr 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Apr 2026May 2026

First Submitted

Initial submission to the registry

April 18, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

April 20, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 23, 2026

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2026

Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

1 month

First QC Date

April 18, 2026

Last Update Submit

April 18, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Zarit Caregiver Burden Scale (Zarit Burden Interview, ZBI)

    Caregiver burden will be assessed using the Zarit Caregiver Burden Scale. Higher scores indicate greater caregiver burden.

    Baseline

Secondary Outcomes (5)

  • Insomnia Severity Index (ISI)

    Baseline

  • Hospital Anxiety and Depression Scale - Anxiety Subscale (HADS-A)

    Baseline

  • Hospital Anxiety and Depression Scale - Depression Subscale (HADS-D)

    Baseline

  • Expanded Disability Status Scale (EDSS)

    Baseline

  • Multiple Sclerosis Impact Scale (MSIS)

    Baseline

Interventions

No intervention

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Multiple sclerosis and caregivers

You may qualify if:

  • Age 18-80 years
  • Clinically diagnosed with multiple sclerosis by a neurologist
  • Being followed in the physical therapy and rehabilitation clinics during the study period
  • Having a primary or regular caregiver (family member)
  • Both patient and caregiver able to read and understand Turkish and complete questionnaires
  • Willing to participate and provide written informed consent

You may not qualify if:

  • Severe cognitive impairment or communication problems preventing questionnaire completion
  • Acute relapse or hospitalization due to exacerbation within the last month
  • Severe comorbid neurological, psychiatric, or systemic disease affecting assessments
  • Caregiver \<18 years old or not providing regular care
  • Paid professional caregiver
  • Caregiver with severe psychiatric, neurological, or primary sleep disorder
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Physical Medicine and Rehabilitation Trainig and Research Hospital

Istanbul, Bahcelievler, 34100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 18, 2026

First Posted

April 23, 2026

Study Start

April 20, 2026

Primary Completion (Estimated)

May 20, 2026

Study Completion (Estimated)

May 20, 2026

Last Updated

April 23, 2026

Record last verified: 2026-04

Locations